02/14/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:05 PM | Citius Pharmaceuticals (Filer)
| Form DEF 14A | |
01/27/2025
3:07 PM | Citius Pharmaceuticals (Filer)
| Form DEFA14A | |
01/16/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form PRE 14A | |
01/08/2025
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
8:00 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
01/07/2025
8:11 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:00 PM | Citius Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/20/2024
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CTXR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/27/2024
3:05 PM | Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
| Form SC 13D/A | |
11/25/2024
4:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:26 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:27 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:26 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:34 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
| Form SC 13D | |
08/16/2024
3:35 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
5:19 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:25 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:51 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
9/9 on TSLA from June to January (Ad) Please take a look at THIS case study on Target (TGT)
You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite.
Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured.
And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts! Tap here to catch the TGT case study and learn more |
05/08/2024
1:22 PM | BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/30/2024
3:21 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2024
11:15 PM | Citius Pharmaceuticals (Filer)
| Form EFFECT | |
02/23/2024
3:23 PM | Citius Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/23/2024
3:18 PM | Citius Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
